​

Medifast (MED) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MED Stock Forecast

Medifast (MED) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $83.50, with a high of $150.00 and a low of $17.00. This represents a 534.50% increase from the last price of $13.16.

- $30 $60 $90 $120 $150 High: $150 Avg: $83.5 Low: $17 Last Closed Price: $13.16

MED Stock Rating

Medifast stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (50.00%), 4 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 4 4 Strong Sell Sell Hold Buy Strong Buy

MED Price Target Upside V Benchmarks

TypeNameUpside
StockMedifast534.50%
SectorConsumer Cyclical Stocks 16.11%
IndustryPersonal Services Stocks 0.83%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$17.00
Last Closing Price$13.16$13.16$13.16
Upside/Downside--29.18%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25--1--1
May, 25--1--1
Apr, 25--2--2
Mar, 25--2--2
Feb, 25--2--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 05, 2024Linda Bolton WeiserD.A. Davidson$17.00$20.40-16.67%29.18%
Jun 05, 2024Linda Bolton WeiserD.A. Davidson$17.50$23.97-26.99%32.98%
Apr 30, 2024Linda Bolton WeiserD.A. Davidson$25.00$35.51-29.60%89.97%
Jun 05, 2023Stephanie WissinkJefferies$150.00$81.2284.68%1039.82%
Apr 06, 2023Linda Bolton WeiserD.A. Davidson$94.00$96.39-2.48%614.29%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 22, 2023CitigroupHoldHoldhold
Jun 21, 2023CitigroupNeutralNeutralhold
Nov 04, 2022Redburn PartnersSellinitialise
Aug 04, 2022JefferiesHolddowngrade

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$8.74$14.01$12.82$9.13$0.19--
Avg Forecast$9.24$13.63$13.05$9.52$1.77$0.30$0.50
High Forecast$9.30$13.73$13.42$9.55$1.93$0.54$0.52
Low Forecast$9.18$13.54$12.67$9.49$1.58$0.11$0.48
Surprise %-5.41%2.79%-1.76%-4.10%-89.27%--

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$934.84M$1.53B$1.60B$1.07B$602.46M--
Avg Forecast$919.16M$1.52B$1.59B$1.07B$597.70M$509.85M$509.20M
High Forecast$923.91M$1.53B$1.63B$1.10B$615.06M$524.66M$523.99M
Low Forecast$914.40M$1.52B$1.56B$1.03B$580.34M$495.04M$494.41M
Surprise %1.71%0.13%0.45%0.64%0.80%--

Net Income Forecast

$0 $40M $80M $120M $160M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$102.86M$164.03M$143.57M$99.42M$2.09M--
Avg Forecast$87.91M$131.12M$148.17M$99.42M$19.16M$3.25M$5.40M
High Forecast$105.49M$157.34M$177.81M$119.30M$21.06M$5.91M$5.67M
Low Forecast$70.33M$104.89M$118.54M$79.53M$17.26M$1.22M$5.25M
Surprise %17.00%25.10%-3.11%--89.09%--

MED Forecast FAQ

Is Medifast stock a buy?

Medifast stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Medifast is a favorable investment for most analysts.

What is Medifast's price target?

Medifast's price target, set by 8 Wall Street analysts, averages $83.5 over the next 12 months. The price target range spans from $17 at the low end to $150 at the high end, suggesting a potential 534.50% change from the previous closing price of $13.16.

How does Medifast stock forecast compare to its benchmarks?

Medifast's stock forecast shows a 534.50% upside, outperforming the average forecast for the consumer cyclical stocks sector (16.11%) and outperforming the personal services stocks industry (0.83%).

What is the breakdown of analyst ratings for Medifast over the past three months?

  • June 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Medifast’s EPS forecast?

Medifast's average annual EPS forecast for its fiscal year ending in December 2025 is $0.3, marking a 57.89% increase from the reported $0.19 in 2024. Estimates for the following years are.

What is Medifast’s revenue forecast?

Medifast's average annual revenue forecast for its fiscal year ending in December 2025 is $509.85M, reflecting a -15.37% decrease from the reported $602.46M in 2024. The forecast for.

What is Medifast’s net income forecast?

Medifast's net income forecast for the fiscal year ending in December 2025 stands at $3.25M, representing an 55.43% increase from the reported $2.09M in 2024. Projections indicate .